NCT05031260

Brief Summary

This is a clinical study to evaluate the safety and effectiveness of COMORAL®, the intraoral water-spraying cleaning device that is developed to remove plaque around teeth in the oral cavity. To do so, 42 healthy subjects, 21 control and 21 experimental, will be recruited. To establish the baseline, all subjects will receive dental hygiene service. After 2 weeks, patients will be randomly assigned to either control or intervention group (21 individuals each). Both groups will be asked to brush their teeth once a day but without dental floss, mouth rinse, and gum chewing, throughout the 4 weeks of study period. During the study period, the experimental group will receive COMORAL® treatment three times a day every day for 4 weeks except Saturday and Sunday. Subjects will get evaluated for the oral status(PI, BOP, GI, PD, GR, CAL) and the status of periopathogens on visit 1, visit 2 and visit 3.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2021

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 20, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 1, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2021

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
Last Updated

September 1, 2021

Status Verified

August 1, 2021

Enrollment Period

2 months

First QC Date

July 20, 2021

Last Update Submit

August 26, 2021

Conditions

Keywords

COMORALthe oral irrigation unit

Outcome Measures

Primary Outcomes (6)

  • gingival index (GI)

    the scoring system for mild inflammation(modified gingival index)

    Baseline, 2 weeks, 4 weeks

  • plaque index (PI)

    the amount of dental plaque visible on the vestibular and lingual surfaces

    Baseline, 2 weeks, 4 weeks

  • bleeding on probing (BOP)

    the scoring system recorded 20 seconds after probing the depth of the pocket

    Baseline, 2 weeks, 4 weeks

  • pocket depth (PD)

    the distance from the gingival margin to pocket base

    Baseline, 2 weeks, 4 weeks

  • gingival recession (GR)

    the distance of the displacement of marginal gingiva apical to the cemento-enamel junction

    Baseline, 2 weeks, 4 weeks

  • clinical attachment loss (CAL)

    the distance between the cementoenamel junction and the base of the probeable pocket

    Baseline, 2 weeks, 4 weeks

Secondary Outcomes (1)

  • Periopathogens (PP)

    Baseline, 2 weeks, 4 weeks

Study Arms (2)

Control group

NO INTERVENTION

The individuals in the control group will be asked to brush their teeth (2x per day) at home throughout the 4 weeks of study period. They will be asked not to use the supplementary oral hygiene products including mouth rinse, dental floss and chewing gum.

Experimental group

EXPERIMENTAL

The individuals in this group will be asked to brush their teeth (2x per day) at home throughout the 4 weeks of study period. They will be asked not to use the supplementary oral hygiene products including mouth rinse, dental floss and chewing gum. Instead, they will be asked to come to the clinic to use COMORAL® three times a day, every day except Saturday and Sunday.

Device: applying COMORAL®

Interventions

The individuals in the experimental group will be asked to come to the clinic to use COMORAL® three times a day, every day except Saturday and Sunday.

Experimental group

Eligibility Criteria

Age18 Years - 25 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy adult patients (ASA 1-2) aged 18 to 25 with a probing depth of 3mm or less
  • Those with 3 or more natural teeth in each quartile
  • Those who can voluntarily sign the consent form

You may not qualify if:

  • Existing dental caries
  • Existing periodontitis
  • Other oral diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

GingivitisPlaque, Amyloid

Condition Hierarchy (Ancestors)

InfectionsGingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Reuben Kim, DDS, PhD

    University of California, Los Angeles

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Reuben Kim, DDS, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Chair

Study Record Dates

First Submitted

July 20, 2021

First Posted

September 1, 2021

Study Start

October 1, 2021

Primary Completion

November 30, 2021

Study Completion

June 30, 2022

Last Updated

September 1, 2021

Record last verified: 2021-08